Palisade Bio Inc (NASDAQ:PALI) has a beta value of 1.25 and has seen 10.99 million shares traded in the recent trading session. The company, currently valued at $6.41M, closed the recent trade at $7.55 per share which meant it gained $1.52 on the day or 25.15% during that session. The PALI stock price is -384.77% off its 52-week high price of $36.60 and 49.4% above the 52-week low of $3.82. The 3-month trading volume is 915.87K shares.

Palisade Bio Inc (NASDAQ:PALI) trade information

Sporting 25.15% in the green today, the stock has traded in the green over the last five days, when the PALI stock price touched $7.55 or saw a rise of 16.94%. Year-to-date, Palisade Bio Inc shares have moved -14.73%, while the 5-day performance has seen it change 18.84%. Over the past 30 days, the shares of Palisade Bio Inc (NASDAQ:PALI) have changed 31.56%.

Palisade Bio Inc (PALI) estimates and forecasts

Figures show that Palisade Bio Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -7.89% over the past 6 months, with this year growth rate of 54.46%, compared to 12.60% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 40.70% and 43.40% for the next quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 75.28% over the past 5 years.

PALI Dividends

Palisade Bio Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.